Results 211 to 220 of about 1,442,598 (260)

Clinical phenotypes, endotypes, and biomarker profiles of immediate rituximab hypersensitivity reactions: a prospective pharmacovigilance study. [PDF]

Front Allergy
Yotinnoratham N, Laisuan W, Chanprapaph K, Kanokrungsee S, Setthaudom C, Onpun S, Mongkolpathumrat P, Buranapraditkun S, Chungcharoenpanich A, Dechapaphapitak N, Oncham S, Tongdee N, Khamkaew S, Lertnawapan R, Klaewsongkram J.   +14 more
europepmc   +1 more source

Induced Core‐Shell Transformation in Agarose‐Chitosan Nanoreactor Beads Enable Single Channel Coding for dPCR Multiplexing

Small, EarlyView.
Hybrid agarose–chitosan beads undergo a pH‐dependent reorganization into stable core–shell structures upon heating. The resulting tunable optical shell/core contrasts enable bead‐based coding for multiplex PCR. This approach allows sample multiplexing with simple detection systems and functionally exploits a previously unrecognized structure‐forming ...
Katharina Heise, Lennart Gura, Emma Pohl, Lea Kanitz, Theresa Liebe, Daniel Toro, Katrin Steinmetzer, Thomas Ellinger, Susanne Klingner, Stephan Hubold, Oliver Lemuth, Susanne Töpfer, Eugen Ermantraut   +12 more
wiley   +1 more source

Disruptive innovation events in dentistryPractical Implications

JADA Foundational Science
Jill Sirko, PhD, Wenyuan Shi, PhD
doaj   +1 more source

Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis. [PDF]

Adv Rheumatol
Wang X, Wu T, Xia X, Xing Q, Shi J, Xu S.   +5 more
europepmc   +1 more source

Private to Public: Deterrent Effects of Bans on Confidential Settlements

Southern Economic Journal, EarlyView.
ABSTRACT Nondisclosure agreements are common in the settlement of legal disputes but are controversial as they suppress information that could prevent harm to others. But until the 2017 #MeToo movement, there had been little legislative effort to prohibit the practice in any context, and consequently no evidence on whether public disclosure of harms ...
Blair Druhan Bullock, Joni Hersch
wiley   +1 more source

Targeted HA@Que-Mn nanozymes alleviate postherpetic neuralgia by modulating neuroinflammation. [PDF]

Mater Today Bio
Liu Y, Zhao M, Li L, Yang Y, Wang S, Lin Z, Chen J, Lai Y, Tang S, Zhang X, Wu X, Zhou J.   +11 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars. [PDF]

Bioanalysis
Krishnan A, Bp S, Mehta G, Ramaswamy S, Chakraborty S, Mandal S.   +5 more
europepmc   +1 more source

MAPFL: Modular Adaptive Personalised Federated Learning From Visual Sentiment to Physical Activity

CAAI Transactions on Intelligence Technology, EarlyView.
ABSTRACT Human‐centric sensing tasks such as visual sentiment analysis and smartphone‐based human activity recognition (HAR) exhibit strong client heterogeneity from feature, label, and concept shifts. Among these, concept shift—how individual users interpret and generate human‐centric signals—is particularly challenging yet underexplored in federated ...
Chang Liu, Yapeng Li, Zengmao Wang, Dewen Soh, Bo Du   +4 more
wiley   +1 more source